Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. (Q51424093)
Jump to navigation
Jump to search
scientific article published on 27 September 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. |
scientific article published on 27 September 2016 |
Statements
1 reference
Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli. (English)
1 reference
1 reference
Stina Söderlund
1 reference
Lisa Christiansson
1 reference
Inger Persson
1 reference
Henrik Hjorth-Hansen
1 reference
Johan Richter
1 reference
Bengt Simonsson
1 reference
Ulla Olsson-Strömberg
1 reference
Angelica Loskog
1 reference
27 September 2016
1 reference
1 reference
50
1 reference
95-103
1 reference
Identifiers
1 reference